Atlas Trials

A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes

Clinical trial NCT01950468 · WITHDRAWN

Trial details

NCT number
NCT01950468
Sponsor
Navidea Biopharmaceuticals
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Parkinson's Syndrome
Start date
2017-04-01
Primary completion
2018-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.